Loading…
Hemant Surgical Industries (BSE 543916)₹636.00+1.17%Medical Equipment & Supplies
In the Mar 2026 quarter (consolidated), Hemant Surgical Industries reported sales of ₹167 Cr, up 187.9% from Mar 2025, and net profit of ₹12.96 Cr, up 159.7% year on year. For the year to Mar 2026, sales were ₹232 Cr and net profit ₹17.95 Cr.
Company filings, consolidated accounts; latest reported quarter Mar 2026
| Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|
| Sales | 57.98 | 64.99 | 167 |
| Expenses | 52.01 | 56.99 | 152 |
| Operating Profit | 5.01 | 8.01 | 16.01 |
| OPM % | 9.0% | 12.0% | 9.0% |
| Other Income | 3.01 | 2.01 | 3.99 |
| Interest | 1.01 | 2.01 | 2.01 |
| Depreciation | 1.01 | 1.01 | 1.01 |
| Profit before tax | 6.01 | 7.01 | 16.01 |
| Tax % | 19.1% | 25.1% | 22.0% |
| Net Profit | 4.99 | 4.98 | 12.96 |
| EPS (Rs) | 4.64 | 4.17 | 9.72 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Sales | 107 | 232 |
| Expenses | 98.01 | 209 |
| Operating Profit | 9.01 | 23.02 |
| OPM % | 9.0% | 10.1% |
| Other Income | 5.01 | 5.99 |
| Interest | 2.01 | 4.01 |
| Depreciation | 1.01 | 2.01 |
| Profit before tax | 10.01 | 24.01 |
| Tax % | 23.1% | 23.0% |
| Exceptional items | 0.00 | 0.00 |
| Net Profit | 7.98 | 17.95 |
| EPS (Rs) | 7.67 | 13.90 |
| Dividend payout % | 0.0% | 0.0% |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Equity Capital | 10.03 | 13.04 |
| Reserves | 52.87 | 125 |
| Borrowings | 30.91 | 49.89 |
| Other Liabilities | 54.13 | 87.42 |
| Total Liabilities | 148 | 274 |
| Fixed Assets | 40.07 | 53.08 |
| CWIP | 11.99 | 0.00 |
| Investments | 1.01 | 0.00 |
| Other Assets | 94.87 | 221 |
| Inventories | 42.91 | 58.89 |
| Trade receivables | 19.99 | 66.96 |
| Cash & equivalents | 9.99 | 43.99 |
| Total Assets | 148 | 274 |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Cash from operating activity | 8.99 | −31.97 |
| Cash from investing activity | −30.03 | −3.01 |
| Cash from financing activity | 17.93 | 68.74 |
| Net cash flow | −4.01 | 34.10 |
| Capex | 38.80 | 2.14 |
| Free cash flow | −25.99 | −34.01 |
| CFO / OP % | 118.1% | −119.0% |
| Mar 2025 | Mar 2026 | |
|---|---|---|
| Debtor days | 70 | 106 |
| Inventory days | 209 | 122 |
| Days payable | 189 | 147 |
| Cash conversion cycle | 89 | 80 |
| Working capital days | 62 | 24 |
| ROCE % | — | 19.9% |
For the Mar 2026 quarter, Hemant Surgical Industries reported sales of ₹167 Cr, up 187.9% year on year and net profit of ₹12.96 Cr, up 159.7% year on year. The operating margin was 9.0%.
Hemant Surgical Industries' sales for the year to Mar 2026 were ₹232 Cr.
Net profit for the year to Mar 2026 was ₹17.95 Cr. Earnings per share over the same trailing period were ₹13.90.
Hemant Surgical Industries reported borrowings of ₹49.89 Cr at Mar 2026, against cash and equivalents of ₹43.99 Cr.
Cash from operations was −₹31.97 Cr in the year to Mar 2026; after capital spending, free cash flow was −₹34.01 Cr.